We are live on ! Find out more
MRSN

Mersana Therapeutics

Delisted

MRSN was delisted on the 5th of January, 2026.

42 hedge funds and large institutions have $302M invested in Mersana Therapeutics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

45% more funds holding

Funds holding: 2942 (+13)

28% more capital invested

Capital invested by funds: $236M → $302M (+$65.6M)

0.08% more ownership

Funds ownership: 3%3.08% (+0.08%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
42
Holders Change
+13
Holders Change %
+44.83%
% of All Funds
1.05%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
24
Increased
5
Reduced
7
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Credit Agricole
51
Credit Agricole
France
-$70K -200 Closed
GGHC
52
Gilder Gagnon Howe & Co
New York
-$70K -200 Closed
WCMNY
53
Westchester Capital Management (New York)
New York
-$7K -20 Closed